Erin leads Life Sciences Queensland as our Chief Executive Officer. She is an experienced organisational and entrepreneurial leader with a strong focus on strategic partnership and innovation spanning industries including biotech, digital technology, defence and higher education. She brings two decades growing peak body organisations through delivery of member value, strategic policy advice, advocacy and engagement.
She started her career in the Biotechnology, completing her PhD at University of Queensland. She worked in the Pharma-Biotech industry in Australia and then in Europe and North America working with Abbott, Allergan, Genzyme (now Sanofi) and IQVIA leading global clinical development and quality.
Erin is cofounder of a tech start-up and prior to joining LSQ she grew the team and launched the product globally securing venture capital and international partnerships.
She is adjunct faculty at the Queensland University of Technology and in the Queensland Health Improvement Fellowship specialising in systems thinking and leading in complexity. Working with QUT she has delivered over 25 DFAT programs across the Asia-Pacific and is passionate about connecting with our vibrant region.
Erin is Chair of Health Consumers Queensland, the Queensland Health Consumer Collaborative and sits on the Executive for the Clinical Senate and Clinical Networks. She worked on the pandemic response and vaccine rollout with Queensland Health and diverse NGOs to enable a consumer-focused approach. She led the Queensland Genomics Advisory Board delivering projects to mainstream genomics providing health equity and access for all Queenslanders. She is a founding member of the Queensland XR Hub Advisory Board.
Erin has an MBA and is a graduate of Australian Institute of Company Directors and the Advisory Board Centre.